Business News
Financial news, mergers and acquisitions, partnerships, and alliances.
In Brief This Week: PerkinElmer, Chembio, Becton Dickinson, Fulgent Genetics, and More
News items for the in vitro diagnostic industry for the week of Sept. 20, 2021.
Kephera Diagnostics Wins $300K NIH Grant for Chagas Disease Test
The test will be designed in both laboratory-based and point-of-care formats to address the needs of clinical and field settings.
Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO
Lucid Diagnostics said it markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for the early detection of esophageal precancer and cancer.
Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy
Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications.
Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test
The firm's health screening sequencing assay, which retails at $249 and covers a panel of over 400 genes, will now be available to consumers in all 50 states.